Jayanthi Repalli, PhD
3 SlideShares 11 Abonné 22 Suivis
Mots-clés
life sciences drug development pharmaceutical analytics patient big data blockchain clinial trials digital strategy drug discovery alzheimer's disease target identification machine learning insights neurological disorders medicine dementia lead generation target artificial intelligence privacy wearables better outcomes payers control security internet of things health data providers patient centered care healthcare patient engagement technology personalized medicine open data information security innovation research disease awareness
Tout plus

Présentations

(3)

Digital platforms could disrupts how pharma companies plan and excecute clinical trials

il y a 7 ans • 665 Vues

Blockchain in life sciences

il y a 7 ans • 2263 Vues

AI applications in life sciences - drug development

il y a 7 ans • 4105 Vues

J’aime

(3)

Patient as an Asset - Mark duman

Bart de Witte • il y a 9 ans

The Blockchain as a Software Connector

Cesare Pautasso • il y a 8 ans

A Swiss Statistician's 'Big Tent' Overview of Big Data and Data Science in Pharmaceutical Development (Version 12)

Prof. Dr. Diego Kuonen • il y a 7 ans
Mots-clés
life sciences drug development pharmaceutical analytics patient big data blockchain clinial trials digital strategy drug discovery alzheimer's disease target identification machine learning insights neurological disorders medicine dementia lead generation target artificial intelligence privacy wearables better outcomes payers control security internet of things health data providers patient centered care healthcare patient engagement technology personalized medicine open data information security innovation research disease awareness
Tout plus